FDC
Back to Cashflow Statement
|
FDC Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Operating Activities | ₹221 Cr | ₹155 Cr | ₹162 Cr | ₹207 Cr | ₹250 Cr |
What is the latest Cash Flow from Operating Activities ratio of FDC ?
Year | Cash Flow from Operating Activities |
---|---|
Mar2024 | ₹221 Cr |
Mar2023 | ₹155 Cr |
Mar2022 | ₹162 Cr |
Mar2021 | ₹207 Cr |
Mar2020 | ₹250 Cr |
How is Cash Flow from Operating Activities of FDC Trending?
Years | Cash Flow from Operating Activities | % Change | |
---|---|---|---|
Mar2024 | ₹221 Cr | 42.51 | |
Mar2023 | ₹155 Cr | -4.17 | |
Mar2022 | ₹162 Cr | -21.94 | |
Mar2021 | ₹207 Cr | -17.29 | |
Mar2020 | ₹250 Cr | - |
Compare Cash Flow from Operating Activities of peers of FDC
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
FDC | ₹6,995.5 Cr | 1.3% | 4.2% | -3.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹418,648.0 Cr | -3.4% | -0.2% | 18.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,310.0 Cr | -2.3% | 3.4% | 55.5% | Stock Analytics | |
CIPLA | ₹119,410.0 Cr | -2.6% | -0.6% | 5.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹106,189.0 Cr | -2.3% | -2.1% | 20.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹96,496.4 Cr | -2.9% | -0.2% | -8.7% | Stock Analytics |
FDC Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
FDC | 1.3% |
4.2% |
-3.6% |
SENSEX | -1.3% |
4.1% |
7.6% |
You may also like the below Video Courses